---
figid: PMC6781272__pharmaceutics-11-00441-g001
figtitle: 'Generalized Toll-like receptor signaling mechanism, adapted from '
organisms:
- Adenoviridae
- Human immunodeficiency virus
- Enterovirus
- Simian immunodeficiency virus
- ssRNA viruses
- dsRNA viruses
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Helicobacter pylori
- Listeria monocytogenes
- Aspergillus fumigatus
- Toxoplasma gondii
- Phytolacca americana
- Homo sapiens
- Danio rerio
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6781272
filename: pharmaceutics-11-00441-g001.jpg
figlink: /pmc/articles/PMC6781272/figure/pharmaceutics-11-00441-f001/
number: F1
caption: 'A generalized Toll-like receptor signaling mechanism, adapted from []. TLRs
  are subdivided into two main categories based on their location, cell surface or
  endosomal; they are activated by their respective PAMPs and damage-associated molecular
  patterns. After recognizing respective ligand(s) via extracellular domains, TLRs
  form homo- or heterodimers and interact with cytoplasmic adaptor molecules (myeloid
  differentiation primary response protein 88 (MyD88), TIRAP (MAL), TRIF, or TRAM)
  through their cytoplasmic TIR domain. Most of TLRs activate downstream signaling
  in a MyD88-dependent manner with or without recruiting MAL; however, TLR3 (only)
  and TLR4 (alternatively) use TRIF/TRAM adaptors to activate IRFs. The activation
  of a TLR signaling pathway leads to the translocation of transcription factors (NF-κB
  (p50 or p65), AP-1, IRF3, and IRF7) into the nucleus and allows them to bind the
  target sequence(s) of inflammatory and interferon-responsive genes. Abbreviations:
  TLR, Toll-like receptor; TIR, Toll/interleukin-1 receptor domain; MAL, MyD88 adaptor
  like; MyD88, myeloid differentiation primary response 88; TRAM, TRIF-related adaptor
  molecule; TRIF, TIR domain-containing adaptor inducing interferon β; IRAK, interleukin
  receptor-associated kinase; RIP, receptor-interacting protein; TRAF, tumor necrosis
  factor receptor (TNFR)-associated factor; TAB, TAK-1–binding protein; TAK1, transforming
  growth factor β-activated kinase 1; TBK1, TANK-binding kinase 1; NEMO, NF-κB essential
  modulator; IκB, inhibitor of κB; IKK, inhibitor of κB kinase; MAP, mitogen-activated
  protein; ERK, extracellular signal–regulated kinase; JNK, c-Jun N-terminal kinase;
  p38, protein 38; AP-1, activated protein 1; IFN, interferon; IL, interleukin; IRF,
  interferon response factor; NF-κB, nuclear factor κB; TNF-α, tumor necrosis factor
  α.'
papertitle: Toll-Like Receptors and Relevant Emerging Therapeutics with Reference
  to Delivery Methods.
reftext: Nasir Javaid, et al. Pharmaceutics. 2019 Sep;11(9):441.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9607897
figid_alias: PMC6781272__F1
figtype: Figure
redirect_from: /figures/PMC6781272__F1
ndex: aecfe427-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6781272__pharmaceutics-11-00441-g001.html
  '@type': Dataset
  description: 'A generalized Toll-like receptor signaling mechanism, adapted from
    []. TLRs are subdivided into two main categories based on their location, cell
    surface or endosomal; they are activated by their respective PAMPs and damage-associated
    molecular patterns. After recognizing respective ligand(s) via extracellular domains,
    TLRs form homo- or heterodimers and interact with cytoplasmic adaptor molecules
    (myeloid differentiation primary response protein 88 (MyD88), TIRAP (MAL), TRIF,
    or TRAM) through their cytoplasmic TIR domain. Most of TLRs activate downstream
    signaling in a MyD88-dependent manner with or without recruiting MAL; however,
    TLR3 (only) and TLR4 (alternatively) use TRIF/TRAM adaptors to activate IRFs.
    The activation of a TLR signaling pathway leads to the translocation of transcription
    factors (NF-κB (p50 or p65), AP-1, IRF3, and IRF7) into the nucleus and allows
    them to bind the target sequence(s) of inflammatory and interferon-responsive
    genes. Abbreviations: TLR, Toll-like receptor; TIR, Toll/interleukin-1 receptor
    domain; MAL, MyD88 adaptor like; MyD88, myeloid differentiation primary response
    88; TRAM, TRIF-related adaptor molecule; TRIF, TIR domain-containing adaptor inducing
    interferon β; IRAK, interleukin receptor-associated kinase; RIP, receptor-interacting
    protein; TRAF, tumor necrosis factor receptor (TNFR)-associated factor; TAB, TAK-1–binding
    protein; TAK1, transforming growth factor β-activated kinase 1; TBK1, TANK-binding
    kinase 1; NEMO, NF-κB essential modulator; IκB, inhibitor of κB; IKK, inhibitor
    of κB kinase; MAP, mitogen-activated protein; ERK, extracellular signal–regulated
    kinase; JNK, c-Jun N-terminal kinase; p38, protein 38; AP-1, activated protein
    1; IFN, interferon; IL, interleukin; IRF, interferon response factor; NF-κB, nuclear
    factor κB; TNF-α, tumor necrosis factor α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tlr5
  - Tlr10
  - Tlr1
  - Tlr2
  - Tlr6
  - Tlr4
  - Tlr9
  - Tlr3
  - Tlr8
  - Tlr7
  - Myd88
  - Irak1
  - Traf6
  - Irak4
  - Rnf138
  - Map3k7
  - Tab2
  - Ikbkg
  - Chuk
  - Ralbp1
  - Tbk1
  - Traf3
  - Syt1
  - Mapk14
  - Ephb1
  - Mapk8
  - Irf7
  - Irf3
  - Il12b
  - Tnf
  - Il6
  - Ifnb1
  - Tirap
  - Mal
  - TLR5
  - TLR10
  - TLR1
  - TLR2
  - TLR6
  - TLR4
  - TLR9
  - TLR3
  - TLR8
  - TLR7
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - MYD88
  - IRAK1
  - TRAF6
  - IRAK4
  - TRIM69
  - TICAM1
  - MAP3K7
  - NR2C2
  - TAB2
  - TAB1
  - TAB3
  - IKBKG
  - CHUK
  - IKBKB
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - TBK1
  - TRAF3
  - SGSM3
  - IKBKE
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - EPHB2
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - IRF7
  - IRF3
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - IL12A
  - IL12B
  - TNF
  - IL6
  - CXCL8
  - IFNB1
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - TIRAP
  - MAL
  - MRTFA
  - Tmed7
  - Ticam2
  - Trim69
  - Ticam1
  - Nr2c2
  - Ikbkb
  - Ripk1
  - Ikbke
  - Nfkbib
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Ephb2
  - Mapk1
  - Jun
  - Cxcl15
  - Ifna
  - Mrtfa
  - tlr5b
  - tlr1
  - tlr2
  - tlr9
  - tlr3
  - tlr7
  - tram1
  - myd88
  - irak1
  - traf6
  - irak4
  - ticam1
  - tab2
  - ikbkg
  - ripk1l
  - tbk1
  - traf3
  - pak2a
  - itpka
  - nfkb1
  - rela
  - mapk14a
  - mapk8b
  - irf7
  - irf3
  - tnfa
  - tnfb
  - il6
  - cxcl8a
  - tirap
  - malb
  - tok
  - tlr-2
  - Toll-4
  - TRAM
  - Tak1
  - Abd-B
  - nmo
  - IKKbeta
  - Traf-like
  - mapP
  - IKKepsilon
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - dl
  - wash
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Erk7
  - rl
  - bsk
  - AP-1gamma
  - Jra
  - kay
  - egr
  - mal
  - bs
  - Mrtf
  - TRAM
  - TAB TAB2
---
